A company by the name of Aneira Pharma is trying to "create the future of hair growth" by commercializing what appears to be a topical combination of a PGE2 analogue + minoxidil.
Here's the patent filing: https://patents.google.com/patent/US20210038600A1/
I only skimmed through it but they also mention bimatoprost, travoprost, tafluprost and possibly others. The patent covers dosages up to 25%.
website: https://www.aneirapharma.com/science
The pictures look decent but I don't know what dosages they used. It could just be the minoxidil that had these results.
While the patent was publicized 2 months ago, Aneira recently received $25m from Valkyrie Group to begin trials.
Whether this makes it to market or not, we'll get useful information from latanoprost in a clinical setting with different dosages.
If all goes well this should come out relatively fast, as latanoprost is already available and the company only has this one product in the pipeline.
Here's the patent filing: https://patents.google.com/patent/US20210038600A1/
I only skimmed through it but they also mention bimatoprost, travoprost, tafluprost and possibly others. The patent covers dosages up to 25%.
website: https://www.aneirapharma.com/science
The pictures look decent but I don't know what dosages they used. It could just be the minoxidil that had these results.
While the patent was publicized 2 months ago, Aneira recently received $25m from Valkyrie Group to begin trials.
Whether this makes it to market or not, we'll get useful information from latanoprost in a clinical setting with different dosages.
If all goes well this should come out relatively fast, as latanoprost is already available and the company only has this one product in the pipeline.